Search by Drug Name or NDC

    NDC 00113-0927-26 Good Sense Tussin DM Max 20; 400 mg/20mL; mg/20mL Details

    Good Sense Tussin DM Max 20; 400 mg/20mL; mg/20mL

    Good Sense Tussin DM Max is a ORAL SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by L. Perrigo Company. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN.

    Product Information

    NDC 00113-0927
    Product ID 0113-0927_05990fb7-dadd-4df2-b6c3-4187022d3980
    Associated GPIs 43997002520905
    GCN Sequence Number 023893
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-5 MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53497
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name Good Sense Tussin DM Max
    Proprietary Name Suffix n/a
    Non-Proprietary Name Dextromethorphan HBr, Guaifenesin
    Product Type HUMAN OTC DRUG
    Dosage Form SOLUTION
    Route ORAL
    Active Ingredient Strength 20; 400
    Active Ingredient Units mg/20mL; mg/20mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
    Labeler Name L. Perrigo Company
    Pharmaceutical Class Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 00113-0927-26 (00113092726)

    NDC Package Code 0113-0927-26
    Billing NDC 00113092726
    Package 1 BOTTLE in 1 CARTON (0113-0927-26) / 118 mL in 1 BOTTLE
    Marketing Start Date 2018-08-06
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.02132
    Pricing Unit ML
    Effective Date 2024-02-21
    NDC Description GS TUSSIN DM MAX LIQUID
    Pharmacy Type Indicator C/I
    OTC Y
    Explanation Code 1, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis

    Standard Product Labeling (SPL)/Prescribing Information SPL d2541ef0-a73c-43aa-91ff-fdbce2748c4f Details

    Revised: 11/2020